CAMBRIDGE, Mass. -- MIT neuroscientists have shown that an enzyme overproduced in the brains of Alzheimer's patients creates a blockade that shuts off genes necessary to form new memories. Furthermore, by inhibiting that enzyme in mice, the researchers were able to reverse Alzheimer's symptoms.
The finding suggests that drugs targeting the enzyme, known as HDAC2, could be a promising new approach to treating the disease, which affects 5.4 million Americans. The number of Alzheimer's victims worldwide is expected to double every 20 years, and President Barack Obama recently set a target date of 2025 to find an effective treatment.
Li-Huei Tsai, leader of the research team, says that HDAC2 inhibitors could help achieve that goal, though it would likely take at least 10 years to develop and test such drugs.
"I would really strongly advocate for an active program to develop agents that can contain HDAC2 activity," says Tsai, director of the Picower Institute for Learning and Memory at MIT. "The disease is so devastating and affects so many people, so I would encourage more people to think about this."
Tsai and her colleagues report the findings in the Feb. 29 online edition of Nature. Lead author of the paper is Johannes Grff, a postdoc at the Picower Institute.
Genome modification
Histone deacetylases (HDACs) are a family of 11 enzymes that control gene regulation by modifying histones proteins around which DNA is spooled, forming a structure called chromatin. When HDACs alter a histone through a process called deacetylation, chromatin becomes more tightly packaged, making genes in that region less likely to be expressed.
HDAC inhibitors can reverse this effect, opening up the DNA and allowing it to be transcribed.
In previous studies, Tsai had shown that HDAC2 is a key regulator of learning and memory. In the new study, her team discovered that inhibiting HDAC2 can reverse A
'/>"/>
| Contact: David Vaughn, Picower dmvaughn@mit.edu 617-452-3342 Massachusetts Institute of Technology Source:Eurekalert |
Related biology news :
1. Hopes for reversing age-associated effects in MS patients
2. Reversing aging
3. New breathing therapy reduces panic and anxiety by reversing hyperventilation
4. Study reveals new possibility of reversing damage caused by MS
5. Preventing or reversing inflammation after heart attack, stroke may require 2-pronged approach
6. Reversing ecology reveals ancient environments
7. Neurimmune Therapeutics Announces Advancement of Alzheimers Program into Preclinical Development
8. Restored wetlands rarely equal condition of original wetlands
9. Using air pollution thresholds to protect and restore ecosystem health
10. New composite material may restore damaged soft tissue
11. Stem cells restore cognitive abilities impaired by brain cancer treatment
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |